Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Invested Capital (2016 - 2026)

Mimedx's Invested Capital history spans 17 years, with the latest figure at $242.9 million for Q1 2026.

  • On a quarterly basis, Invested Capital rose 19.14% to $242.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $242.9 million, a 19.14% increase, with the full-year FY2025 number at $274.5 million, up 29.44% from a year prior.
  • Invested Capital hit $242.9 million in Q1 2026 for Mimedx, down from $274.5 million in the prior quarter.
  • Over the last five years, Invested Capital for MDXG hit a ceiling of $274.5 million in Q4 2025 and a floor of $29.0 million in Q3 2022.
  • Historically, Invested Capital has averaged $137.9 million across 5 years, with a median of $170.2 million in 2024.
  • Biggest five-year swings in Invested Capital: plummeted 36.51% in 2022 and later surged 529.67% in 2023.
  • Tracing MDXG's Invested Capital over 5 years: stood at $30.6 million in 2022, then surged by 529.67% to $192.7 million in 2023, then grew by 10.06% to $212.1 million in 2024, then rose by 29.44% to $274.5 million in 2025, then dropped by 11.51% to $242.9 million in 2026.
  • Business Quant data shows Invested Capital for MDXG at $242.9 million in Q1 2026, $274.5 million in Q4 2025, and $238.9 million in Q3 2025.